These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements. Attie KM; Julius JR; Stoppani C; Rundle AC J Pediatr; 1997 Jul; 131(1 Pt 2):S56-60. PubMed ID: 9255230 [TBL] [Abstract][Full Text] [Related]
5. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree. Silbergeld A; Dastot F; Klinger B; Kanety H; Eshet R; Amselem S; Laron Z J Pediatr Endocrinol Metab; 1997; 10(3):265-74. PubMed ID: 9388817 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity. Thalange NK; Price DA; Gill MS; Whatmore AJ; Addison GM; Clayton PE Pediatr Res; 1996 May; 39(5):849-55. PubMed ID: 8726240 [TBL] [Abstract][Full Text] [Related]
7. Fanconi Anemia and Laron Syndrome. Castilla-Cortazar I; de Ita JR; Aguirre GA; Castorena-Torres F; Ortiz-Urbina J; García-Magariño M; de la Garza RG; Diaz Olachea C; Elizondo Leal MI Am J Med Sci; 2017 May; 353(5):425-432. PubMed ID: 28502327 [TBL] [Abstract][Full Text] [Related]
8. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor. Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ; Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934 [TBL] [Abstract][Full Text] [Related]
9. Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature. Goddard AD; Dowd P; Chernausek S; Geffner M; Gertner J; Hintz R; Hopwood N; Kaplan S; Plotnick L; Rogol A; Rosenfield R; Saenger P; Mauras N; Hershkopf R; Angulo M; Attie K J Pediatr; 1997 Jul; 131(1 Pt 2):S51-5. PubMed ID: 9255229 [TBL] [Abstract][Full Text] [Related]
10. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Zhou Y; Xu BC; Maheshwari HG; He L; Reed M; Lozykowski M; Okada S; Cataldo L; Coschigamo K; Wagner TE; Baumann G; Kopchick JJ Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13215-20. PubMed ID: 9371826 [TBL] [Abstract][Full Text] [Related]
11. Novel growth hormone receptor mutation in a Chinese patient with Laron syndrome. Hui HN; Metherell LA; Ng KL; Savage MO; Camacho-Hübner C; Clark AJ J Pediatr Endocrinol Metab; 2005 Feb; 18(2):209-13. PubMed ID: 15751611 [TBL] [Abstract][Full Text] [Related]
12. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. Binder G; Baur F; Schweizer R; Ranke MB J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706 [TBL] [Abstract][Full Text] [Related]
13. Novel growth hormone receptor gene mutation in a patient with Laron syndrome. Arman A; Yüksel B; Coker A; Sarioz O; Temiz F; Topaloglu AK J Pediatr Endocrinol Metab; 2010 Apr; 23(4):407-14. PubMed ID: 20583548 [TBL] [Abstract][Full Text] [Related]
14. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay. Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696 [TBL] [Abstract][Full Text] [Related]
16. Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer. Janecka A; Kołodziej-Rzepa M; Biesaga B In Vivo; 2016; 30(4):375-81. PubMed ID: 27381597 [TBL] [Abstract][Full Text] [Related]
18. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH. Zhou X; Loke KY; Pillai CC; How HK; Yap HK; Lee KO Eur J Endocrinol; 2001 Mar; 144(3):237-43. PubMed ID: 11248742 [TBL] [Abstract][Full Text] [Related]
19. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients. Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321 [TBL] [Abstract][Full Text] [Related]
20. Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome). Laron Z J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():231-49. PubMed ID: 10698588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]